195 related articles for article (PubMed ID: 32147120)
1. Device Selection in Femoral-Popliteal Arterial Interventions.
Kim SM; Kim LK; Feldman DN
Interv Cardiol Clin; 2020 Apr; 9(2):197-206. PubMed ID: 32147120
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
3. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results.
Brodmann M; Wissgott C; Brechtel K; Nikol S; Zeller T; Lichtenberg M; Blessing E; Gray W;
J Vasc Surg; 2020 Nov; 72(5):1636-1647.e1. PubMed ID: 32414527
[TBL] [Abstract][Full Text] [Related]
4. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
5. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
Mohapatra A; Saadeddin Z; Bertges DJ; Madigan MC; Al-Khoury GE; Makaroun MS; Eslami MH
J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761
[TBL] [Abstract][Full Text] [Related]
6. Femoropopliteal atherosclerosis: do drug-eluting stents improve outcome?
Micari A; Nerla R; Cremonesi A
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e91-e92. PubMed ID: 29538151
[No Abstract] [Full Text] [Related]
7. Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative.
Bertges DJ; Sedrakyan A; Sun T; Eslami MH; Schermerhorn M; Goodney PP; Beck AW; Cronenwett JL; Eldrup-Jorgensen J
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008528. PubMed ID: 32069110
[TBL] [Abstract][Full Text] [Related]
8. Initial Results of Standard Balloon Angioplasty Versus Drug Coated Balloon Alone Versus in Association With Laser Excimer Atherectomy in the Treatment of Femoropopliteal Artery In Stent Restenosis (INTACT).
Ducasse E; Sapoval M; Brunet J; Goueffic Y; Lermusiaux P; Caradu C
Eur J Vasc Endovasc Surg; 2024 May; 67(5):850-851. PubMed ID: 38301872
[No Abstract] [Full Text] [Related]
9. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
12. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
[No Abstract] [Full Text] [Related]
13. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
14. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
[TBL] [Abstract][Full Text] [Related]
15. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
Herten M; Torsello GB; Schönefeld E; Stahlhoff S
Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
[TBL] [Abstract][Full Text] [Related]
16. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
Mehrotra S; Paramasivam G; Mishra S
Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
[TBL] [Abstract][Full Text] [Related]
19. Treating complex femoropopliteal lesions.
van der Vijver-Coppen RJ; 't Mannetje YW; Menting TP; Lardenoije JW; Reijnen MP
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):158-163. PubMed ID: 29327573
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
